Latest SEC Filings
Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.
Greenlane Holdings Regains Nasdaq Compliance; Board & Major Investor Lock Up Shares
La Rosa Holdings Amends 8-K to Include Omitted Pro Forma Financials for February Disposition
Shareholders to Vote on Renewing Board's Authority for Highly Dilutive Capital Raises
Brera Holdings Suspends $250K Monthly Advisory Fee, Boosting Cash Flow
Syntec Optics Registers to Sell $20M in Common Stock at a Premium to Market Price
GGG filing
Apollomics Reports FY25 Financials, Details Turnaround Efforts & Clinical Progress for Vebreltinib
XOMA Royalty Corp Enters Definitive Merger Agreement with Ligand Pharmaceuticals for $39/Share Cash Plus CVR
RedHill Biopharma Reports Going Concern Doubt, Unremediated Material Weakness, and Nasdaq Delisting Risk in 2025 Annual Report
NXPI filing
Oncolytics Biotech Aligns with FDA on Pivotal Anal Cancer Study Design
XOMA Royalty to be Acquired by Ligand Pharmaceuticals for $739M in Cash Plus Contingent Value Rights
GSK's Efimosfermin Receives Dual US FDA Breakthrough & EMA PRIME Designations for MASH
Kennedy-Wilson Holdings Files Amended Going-Private Statement, Details Shareholder Vote for $10.90 Cash Merger
CEO George Guo Resigns Amidst Ongoing Judicial Management Proceedings
Evaxion Promotes Birgitte Rønø to Dual Chief Scientific and Chief Operating Officer Role
TERN-701 Receives FDA Breakthrough Therapy Designation for CML, Accelerating Development Amidst Merck Acquisition
Mirum Pharmaceuticals Reports Positive Phase 2b Results for Brelovitug in Chronic Hepatitis Delta Virus
ASGN filing
PENN filing
CorMedix Announces Positive Phase III Results for REZZAYO, Meeting Primary Endpoint for Fungal Prophylaxis
RedHill Biopharma Reports FY2025 Results: Achieves Positive Equity, Secures Key Partnerships & $10.5M Court Win
Repay Holdings Raises Full-Year Adjusted EBITDA Outlook Amidst Preliminary Q1 Growth
Prologis Prices C$850 Million Senior Unsecured Notes Offering Due 2034
ASGN filing
DMC Global Extends Shareholder Rights Plan (Poison Pill) to 2027 Ahead of Annual Meeting
ULYX filing
MINISO Seeks Shareholder Approval for Potential 5.65% Dilution from Equity-Linked Securities
PENN Entertainment Details Significant Governance Changes, CEO Pay Cut, and Shareholder Proposals in Annual Proxy
Novavax Seeks Shareholder Approval for 10.4M Additional Shares in Equity Plans